Evidence map›Paper›PMID 31479168›Full record

ArticleGlia2020

Imaging of translocator protein upregulation is selective for pro-inflammatory polarized astrocytes and microglia.

Maria Pannell, Vasiliki Economopoulos, Thomas C Wilson, Veerle Kersemans, Patrick G Isenegger, James R Larkin, Sean Smart, Stuart Gilchrist, Véronique Gouverneur, Nicola R Sibson

Open access · hybridAbstract read
In one paragraph

Article in Glia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 3 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 3 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Imaging the inflammatory phenotype in migraine.The journal of headache and pain · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Science advances · 2023
    Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Maria PannellDepartment of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.ORCID 0000-0002-7764-5574
Vasiliki EconomopoulosDepartment of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Thomas C WilsonChemistry Research Laboratory, University of Oxford, Oxford, UK.
Veerle KersemansDepartment of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Patrick G IseneggerChemistry Research Laboratory, University of Oxford, Oxford, UK.
James R LarkinDepartment of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Sean SmartDepartment of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Stuart GilchristDepartment of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Véronique GouverneurChemistry Research Laboratory, University of Oxford, Oxford, UK.
Nicola R SibsonDepartment of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK.
Cancer Research UK · GBUniversity of Oxford · GB

Funding

Biotechnology and Biological Sciences Research Council BB/P026311/1Cancer Research UK 16945Cancer Research UK 23970Cancer Research UK C5255/A12678Cancer Research UK C5255/A15935Cancer Research UK C5255/A16466Medical Research Council MR/R01695X/1
6 · The paper itself

Abstract

Translocator protein (TSPO) expression is increased in activated glia, and has been used as a marker of neuroinflammation in PET imaging. However, the extent to which TSPO upregulation reflects a pro- or anti-inflammatory phenotype remains unclear. Our aim was to determine whether TSPO upregulation in astrocytes and microglia/macrophages is limited to a specific inflammatory phenotype. TSPO upregulation was assessed by flow cytometry in cultured astrocytes, microglia, and macrophages stimulated with lipopolysaccharide (LPS), tumor necrosis factor (TNF), or interleukin-4 (Il-4). Subsequently, mice were injected intracerebrally with either a TNF-inducing adenovirus (AdTNF) or IL-4. Glial expression of TSPO and pro-/anti-inflammatory markers was assessed by immunohistochemistry/fluorescence and flow cytometry. Finally, AdTNF or IL-4 injected mice underwent PET imaging with injection of the TSPO radioligand

Indexed as

AnimalsAstrocytesCarrier ProteinsDisease Models, AnimalInflammationLipopolysaccharidesMacrophagesMiceMicrogliaNeurogliaPositron-Emission TomographyCarrier ProteinsLipopolysaccharidesastrocytesbrain inflammationmicrogliaPETtranslocator protein

Identifiers

PMID31479168
PMCPMC6916298
OpenAlexW2972082263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.